cleaning validation – Page 26

MACO Calculation After HBEL or PDE Revision: Change Control Approach

Implementing MACO Calculations Following Changes in HBEL or PDE Regulations In the pharmaceutical manufacturing environment, adherence to maximum allowable carryover (MACO) calculations is essential to ensure product safety and compliance.…

How to Review Aseptic Process Simulation After Contamination Event

Effective Review of Aseptic Process Simulation Following a Contamination Incident Contamination events in pharmaceutical manufacturing, particularly in aseptic processing, can lead to significant concerns regarding product safety and regulatory compliance.…

Visual Inspection Failures Caused by Poor Equipment Design

Addressing Visual Inspection Failures Stemming from Equipment Design Deficiencies In a highly regulated pharmaceutical environment, visual inspection failures can significantly jeopardize product acceptance and regulatory compliance. Often, these failures can…

How to Recalculate MACO After Product Portfolio Changes

Revising Your MACO Calculation After Adjustments to Product Portfolio In the ever-evolving landscape of pharmaceutical manufacturing, changes to the product portfolio may lead to the necessity of recalculating the Maximum…

Sterility CAPA Effectiveness Checks Inspectors Expect

Assessing CAPA Effectiveness in Sterility and Contamination Deviations In the world of pharmaceutical manufacturing, sterility assurance is paramount. When deviations occur, the ripple effects can jeopardize product quality and regulatory…

How to Manage Disagreement Between QA and Production Inspectors

Managing Conflicts Between QA and Production Inspectors During Visual Inspections Visual inspection failures often lead to disagreements between Quality Assurance (QA) and Production inspectors, impacting product release timelines and compliance.…

MACO Calculation for Shared Facilities with Potent and Non-Potent Products

Effective MACO Calculation in Shared Facilities for Potent and Non-Potent Products In pharmaceutical manufacturing, ensuring compliance for cleaning validation is critical, especially when managing both potent and non-potent products in…

Contamination Deviation Due to Improper Hold Time Control

Addressing Contamination Deviations Linked to Inadequate Hold Time Control Contamination deviations within the pharmaceutical sector present a significant challenge, particularly those stemming from improper hold time control. Understanding how to…

Visual Inspection Failures in CIP and COP Systems

Addressing Visual Inspection Failures in Cleaning-in-Place and Clean-Out-of-Place Systems In the pharmaceutical industry, maintaining high standards of cleanliness during manufacturing processes is paramount. Visual inspection failures often indicate underlying issues…

MACO Calculation for Dedicated Equipment: When Limits Still Matter

Guidelines for MACO Calculation in Dedicated Equipment: Importance of Limits In pharmaceutical manufacturing, the determination of Maximum Allowable Carryover (MACO) is essential when dedicating equipment or facilities to prevent cross-contamination.…

How to Investigate Cross-Contamination vs Microbial Contamination Signals

Navigating the Investigation of Cross-Contamination and Microbial Contamination Indicators In the pharmaceutical industry, managing contamination is a critical aspect of ensuring product safety and compliance. When signals of contamination arise—whether…

How to Include Visual Inspection in Cleaning Validation Protocols

Integrating Visual Inspection in Cleaning Validation Protocols Visual inspection is a critical component of cleaning verification processes in pharmaceutical manufacturing. Failures in visual inspection can lead to contamination, product recalls,…